Galileo Research Facts No. 128: Can Galileo Therapy improve Gait Parameters in Stroke patients significantly?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 128: Can Galileo Therapy improve Gait Parameters in Stroke patients significantly?

Posted by
This study investigated the effects of Galileo Therapy in combination with treadmill therapy on gait parameters in stroke patients (20-30Hz, 4*45sec., 3/week, 6 weeks, 6 different exercises). The control group received treadmill therapy without Galileo (20Min./session). In all reported functional outcome parameters the effects in combination with Galileo Therapy were up to factor 3.25 (+225%) higher than treadmill therapy only...
Continue reading
Galileo Research Facts No. 126: Can Galileo Therapy improve muscle function and muscle cross-section in Cystic Fibrosis?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 126: Can Galileo Therapy improve muscle function and muscle cross-section in Cystic Fibrosis?

Posted by
This study investigated the effects of 6 months of Galileo Therapy on muscle function and cross-section in Cystic Fibrosis patients (12Hz, 6min., 5/week (flexibility) + 26Hz 3/week (muscle power)). The Galileo group showed in average an improvement in muscle cross-section (+5,5%), muscle function (jump height +6,1%) as well as movement efficiency (decrease of used muscle force -4,3% but increase in muscle power +4,7%)...
Continue reading
Galileo Research Facts No. 124: Can Galileo Therapy improve muscle force and endurance in COPD-patients?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 124: Can Galileo Therapy improve muscle force and endurance in COPD-patients?

Posted by
This study investigated the effects of Galileo Therapy in COPD patients. (6-24Hz, 3*3 min., progressive, 150° squat, pos.2-3, 2/week, 3 months, +15 min. warmup+cool-down). The control group received Calisthenics exercises (2*30 min./week). While the control group did not show any significant changes that Galileo group showed highly significant improvements in muscle force and endurance with up to +38% (leg press, 1RM)...
Continue reading
Galileo Research Facts No. 122: Can Galileo Therapy improve muscle function and muscle mass in OI patients?
18 Sep
GRFS, Kids-Therapy

Galileo Research Facts No. 122: Can Galileo Therapy improve muscle function and muscle mass in OI patients?

Posted by
This study documented the effects of Galileo Training in children with OI (Osteogenesis Imperfecta) during the Cologne therapy concept “auf die Beine” on muscle function and muscle mass (10-20Hz, patient individual exercises, 10*15min./week, 6 months + 6 months follow-up). The results showed a significant growth corrected increase of muscle mass (+7%), an significant increase of leg force (+7%) and of the GMFM66 (+9%)...
Continue reading
Galileo Research Facts No. 120: Can Galileo Therapy increase muscle and lung function in Cystic Fibrosis patients?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 120: Can Galileo Therapy increase muscle and lung function in Cystic Fibrosis patients?

Posted by
This study investigated the effects of Galileo Therapy on lung and muscle function of adult Cystic Fibrosis patients (age 24-47, 20-25Hz, pos. 1, 10*3 min./week, 3 months). The results showed that Galileo Therapy could significantly improve lung function (+5%) and muscle function e.g. in the chair rising test (CRT) in muscle power (+16%) and muscle force (+34%)...
Continue reading
Galileo Research Facts No. 118: Can Galileo Therapy + HRT be more effective for bone density than strength training + HRT?
17 Sep
GRFS, Therapy

Galileo Research Facts No. 118: Can Galileo Therapy + HRT be more effective for bone density than strength training + HRT?

Posted by
This study investigated the effects of Galileo Therapy vs. machine based strength training over a period of 1 year (60 min./week) (25Hz, Pos. 3-4, up to 15kg add. weights). Both received hormone replacement therapy (HRT). The control group received strength training at 6 different strength machines (Schnell). The Galileo group showed especially in combination with HRT significant higher effects with up to 3,7% increase aBMD...
Continue reading
GRFS, Therapy

Galileo Research Facts No. 116: Can high frequency Galileo Therapy improve blood-flow in spinal cord injury?

Posted by
This study investigated the effects of Galileo Therapy on blood-flow in spinal cord injury (SCI, ASIA A) patients. They received Galileo Therapy on a Galileo Delta tilt-table (45° tilt, 10-30Hz, pos. 2.5, 60° flexed knees, 3 min., then 2 min. test, blood-flow was measured using ultrasound Doppler). The blood flow improved significantly with increasing frequency and time by up to 54% compared to rest (also at 45° tilt)...
Continue reading
GRFS, Therapy

Galileo Research Facts No. 114: Can Galileo Therapy improve sensory perception in Diabetes Type 2 patients?

Posted by
This study investigated the effects of Galileo Therapy on the sensory perception (perception thresholds) in Diabetes Type 2 patients with diagnosed peripheral neuropathy (12Hz, pos. 1-3, 30° bent knees, 11 min., 3/week, 6 weeks). The control group received identical exercises without vibration. Compared to the control group the Galileo group showed a significant improvement of sensory perception by up to 21% (vibration)...
Continue reading
Galileo Research Facts No. 112: Can Galileo Therapy improve muscle power and balance in MS patients?
17 Sep
GRFS, Therapy

Galileo Research Facts No. 112: Can Galileo Therapy improve muscle power and balance in MS patients?

Posted by
This study investigated safety and the effects of Galileo Therapy on muscle power, balance, flexibility and quality of life in MS (Multiple Sclerosis) patients (15-25Hz, pos. 2.5-4.5, 5-8x1min, 3/week, 8weeks, increasing Intensity). The Galileo group showed significant improvements in Balance (+12,8%), Functional Reach Test (+14.2%), muscle power (Timed up and Go, +10%) and FS-36 Mental Health (+9%)...
Continue reading
Galileo Research Facts No. 107: Can 3 weeks of Galileo Therapy improve power and endurance in COPD patients?
17 Sep
GRFS, Therapy

Galileo Research Facts No. 107: Can 3 weeks of Galileo Therapy improve power and endurance in COPD patients?

Posted by
This pilot study examined the effects of 3 weeks of Galileo Therapy on muscle power and endurance measured by 6 minutes walk test in COPD in-patients. (25Hz, squat, 4*2 min. 5/week, 3 weeks). The control group received identical therapy without Galileo. The Galileo group showed a highly significant improvement in the walking distance by 23% or 68m which is equivalent to over two times the MCID...
Continue reading